MyFinsight
Home
Blog
About
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
2166.57%
Quick Ratio
2166.57%
Cash Ratio
167.66%
Debt to Asset Ratio
45.69%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Accrued rent receivable
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Loan payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
5,541
5,022
5,801
7,688
Restricted cash
254
123
280
150
Marketable securities
64,137
69,549
73,867
84,135
Prepaid expenses and other current assets
1,673
1,512
4,220
3,317
Assets held for sale
-
112,096
112,096
112,096
Total current assets
71,605
188,302
196,264
207,386
Property, plant and equipment, net
111,778
112
138
150
Operating lease right-of-use assets
2,149
60
415
590
Long-term investments
-
-
3,444
11,659
Accrued rent receivable
8,271
7,968
7,360
-
Other long-term assets
3,909
3,986
4,147
11,201
Total assets
197,712
200,428
211,768
230,986
Accounts payable
795
793
928
523
Accrued expenses and other current liabilities
2,510
3,930
4,769
13,329
Total current liabilities
3,305
4,723
5,697
13,852
Contingent consideration
-
-
948
948
Operating lease liabilities, non-current
1,835
-
0
6
Loan payable
85,192
84,999
84,613
84,420
Other long-term liabilities
0
8
88
90
Total liabilities
90,332
89,730
91,346
99,316
Additional paid-in capital
842,958
841,922
839,331
837,185
Accumulated other comprehensive loss
-587
-532
-612
-805
Accumulated deficit
-734,991
-730,692
-718,297
-704,710
Total stockholders equity
107,380
110,698
120,422
131,670
Total liabilities and stockholders equity
197,712
200,428
211,768
230,986
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$64,137K
(-23.77%↓ Y/Y)
Cash and cash
equivalents
$5,541K
(-27.93%↓ Y/Y)
Prepaid expenses and
other current assets
$1,673K
(-49.56%↓ Y/Y)
Restricted cash
$254K
(69.33%↑ Y/Y)
Property, plant and
equipment, net
$111,778K
(74418.67%↑ Y/Y)
Total current assets
$71,605K
(-65.47%↓ Y/Y)
Accrued rent receivable
$8,271K
Other long-term
assets
$3,909K
(-65.10%↓ Y/Y)
Operating lease
right-of-use assets
$2,149K
(264.24%↑ Y/Y)
Total assets
$197,712K
(-14.41%↓ Y/Y)
Total liabilities and
stockholders equity
$197,712K
(-14.41%↓ Y/Y)
Total stockholders
equity
$107,380K
(-18.45%↓ Y/Y)
Total liabilities
$90,332K
(-9.05%↓ Y/Y)
Accumulated deficit
-$734,991K
(-4.30%↓ Y/Y)
Accumulated other
comprehensive loss
-$587K
(27.08%↑ Y/Y)
Additional paid-in capital
$842,958K
(0.69%↑ Y/Y)
Loan payable
$85,192K
(0.91%↑ Y/Y)
Total current
liabilities
$3,305K
(-76.14%↓ Y/Y)
Operating lease
liabilities, non-current
$1,835K
(30483.33%↑ Y/Y)
Accrued expenses and
other current...
$2,510K
(-81.17%↓ Y/Y)
Accounts payable
$795K
(52.01%↑ Y/Y)
Buy us a coffee